Financials China Health Group Limited
Equities
673
BMG2107P2040
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 HKD | -1.16% | -1.16% | -13.27% |
Apr. 09 | China Health Technology Group Terminates 52% Stake Acquisition Deal | MT |
Mar. 01 | China Health Technology Returns to Profit in Fiscal H1 | MT |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 451.4 | 315.2 | 335.3 | 244.3 | 211.1 | 536.5 |
Enterprise Value (EV) 1 | 407.2 | 285.1 | 327.6 | 250.3 | 220.6 | 524.8 |
P/E ratio | -12.5 x | -13.5 x | -9.1 x | -31.1 x | -17.2 x | -11.4 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 18.6 x | 9.8 x | 7.43 x | 2.78 x | 1.97 x | 7.02 x |
EV / Revenue | 16.8 x | 8.86 x | 7.25 x | 2.85 x | 2.06 x | 6.87 x |
EV / EBITDA | -12.6 x | -14.3 x | -12.9 x | -26.1 x | -26.3 x | -51.9 x |
EV / FCF | -18.4 x | -4.92 x | -127 x | -14.9 x | 6.59 x | 1,168 x |
FCF Yield | -5.45% | -20.3% | -0.79% | -6.71% | 15.2% | 0.09% |
Price to Book | 2.8 x | 2.42 x | 3.46 x | 2.57 x | 2.65 x | 6.12 x |
Nbr of stocks (in thousands) | 363,995 | 409,395 | 413,995 | 413,995 | 413,995 | 478,995 |
Reference price 2 | 1.240 | 0.7700 | 0.8100 | 0.5900 | 0.5100 | 1.120 |
Announcement Date | 7/30/18 | 7/31/19 | 7/29/20 | 7/30/21 | 7/31/22 | 7/30/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 24.25 | 32.18 | 45.16 | 87.89 | 107 | 76.41 |
EBITDA 1 | -32.24 | -19.93 | -25.42 | -9.591 | -8.378 | -10.11 |
EBIT 1 | -33.67 | -21.6 | -27.37 | -12.18 | -11.3 | -12.82 |
Operating Margin | -138.85% | -67.13% | -60.6% | -13.86% | -10.56% | -16.78% |
Earnings before Tax (EBT) 1 | -36.72 | -19.92 | -34.34 | -5.331 | -8.709 | -39.38 |
Net income 1 | -39.25 | -23.08 | -36.68 | -7.744 | -12.2 | -42.05 |
Net margin | -161.86% | -71.72% | -81.22% | -8.81% | -11.4% | -55.02% |
EPS 2 | -0.0990 | -0.0570 | -0.0890 | -0.0190 | -0.0296 | -0.0986 |
Free Cash Flow 1 | -22.19 | -57.92 | -2.575 | -16.8 | 33.47 | 0.4494 |
FCF margin | -91.5% | -179.96% | -5.7% | -19.12% | 31.27% | 0.59% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 7/30/18 | 7/31/19 | 7/29/20 | 7/30/21 | 7/31/22 | 7/30/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 6.07 | 9.43 | - |
Net Cash position 1 | 44.2 | 30.2 | 7.73 | - | - | 11.7 |
Leverage (Debt/EBITDA) | - | - | - | -0.633 x | -1.126 x | - |
Free Cash Flow 1 | -22.2 | -57.9 | -2.57 | -16.8 | 33.5 | 0.45 |
ROE (net income / shareholders' equity) | -29% | -15.7% | -30.7% | -6.54% | -9.85% | -44.2% |
ROA (Net income/ Total Assets) | -10.6% | -6.13% | -8.3% | -3.67% | -3.18% | -3.58% |
Assets 1 | 368.7 | 376.5 | 441.8 | 210.9 | 383.5 | 1,173 |
Book Value Per Share 2 | 0.4400 | 0.3200 | 0.2300 | 0.2300 | 0.1900 | 0.1800 |
Cash Flow per Share 2 | 0.1100 | 0.0700 | 0.0200 | 0.0100 | 0.0200 | 0.0200 |
Capex 1 | 0.26 | - | 0.43 | 1.84 | 0.8 | 1.37 |
Capex / Sales | 1.06% | - | 0.95% | 2.09% | 0.74% | 1.79% |
Announcement Date | 7/30/18 | 7/31/19 | 7/29/20 | 7/30/21 | 7/31/22 | 7/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.27% | 53.88M | |
-9.39% | 8.84B | |
-2.35% | 1.4B | |
-7.61% | 1.17B | |
-16.38% | 878M | |
+1.34% | 472M | |
+3.05% | 435M | |
-44.44% | 377M | |
-22.11% | 345M | |
-2.51% | 212M |
- Stock Market
- Equities
- 673 Stock
- Financials China Health Group Limited